EGFR and non-small cell lung carcinoma: COL8A1 has been shown to promote non-small cell lung cancer progression by activating IFIT1/IFIT3-mediated EGFR signaling (32), while FABP5 can promote lymph node metastasis in cervical cancer by reprogramming fatty acid metabolism (33).